Repeat the same answer

I now have comprehensive material from multiple authoritative textbooks. Let me compile the full MD exam-style answer. --- # CPAP (Continuous Positive Airway Pressure) - Full Details for MD Examination --- ## Definition Continuous Positive Airway Pressure (CPAP) is the application of a **continuous positive-pressure threshold during both inspiration and expiration** in a spontaneously breathing patient. It maintains a constant positive pressure throughout the entire respiratory cycle, unlike PEEP (Positive End-Expiratory Pressure), which applies positive pressure only during expiration in mechanically ventilated patients. - Morgan & Mikhail's Clinical Anesthesiology, 7e --- ## Principle / Mechanism of Action CPAP acts as a **pneumatic splint** to the upper airway and the alveoli: 1. **Prevents alveolar collapse** - maintains functional residual capacity (FRC) above closing capacity 2. **Recruits collapsed alveoli** - reexpansion occurs when pressure exceeds the inflection point on the pressure-volume curve 3. **Improves lung compliance** - tidal ventilation occurs on the more compliant portion of the pressure-volume curve 4. **Corrects V/Q mismatch** - reduces intrapulmonary shunting, improving arterial PO2 5. **Redistributes extravascular lung water** - from alveolar-endothelial interstitial space to peribronchial/perihilar areas 6. **In OSA** - acts as a pneumatic stent to prevent upper airway collapse throughout all phases of sleep breathing - Morgan & Mikhail's Clinical Anesthesiology, 7e; Scott-Brown's Otorhinolaryngology --- ## CPAP vs. PEEP (Key Distinction) | Feature | CPAP | PEEP | |---|---|---| | Breathing mode | Spontaneous breathing | Mechanically ventilated | | Pressure applied | During both inspiration AND expiration | During expiration only | | Gas flow required | High continuous flow (60-90 L/min) | Ventilator-cycled | | Artificial airway | Not mandatory (tight mask used) | Usually via ETT | > Note: In clinical practice the two terms are often used interchangeably because patients may breathe with a combination of mechanical and spontaneous breaths. "Pure" CPAP provides sufficient continuous gas flow so that inspiratory airway pressure never falls perceptibly below the expiratory level. --- ## Equipment / Delivery System A CPAP system consists of: 1. **Flow generator** - provides high-flow gas (fixed pressure or autotitrating machines) 2. **Air tubing** connecting to the interface 3. **Mask interface** - options include: - Full face mask - Nasal mask - Nasal pillows (sit on the nostril edge) - Tight-fitting mask for non-OSA ICU use 4. **Humidifier** - recommended for patients with nasal congestion or dry mouth 5. **PEEP/threshold valve** - allows expiratory flow only when airway pressure exceeds set level **Pressure delivered**: Average 5-10 cmH2O for OSA; up to 15 cmH2O maximum via mask (above 15 cmH2O should only be given via endotracheal or tracheostomy tube, to avoid gastric distension and regurgitation) - Morgan & Mikhail's Clinical Anesthesiology, 7e; Scott-Brown's Otorhinolaryngology --- ## Indications ### A. Obstructive Sleep Apnea (OSA) - PRIMARY indication - Treatment of choice for moderate to severe OSA - Also indicated for Upper Airway Resistance Syndrome (UARS)/"sleepy snorers" - Recommended by NICE as treatment of choice for moderate-to-severe OSA ### B. Intensive Care / Respiratory Failure - Decreased FRC causing hypoxemia (absolute or relative) - Impending respiratory failure - can avoid intubation - Acute Respiratory Distress Syndrome (ARDS) - Cardiogenic pulmonary edema / acute left ventricular failure - Post-extubation respiratory failure - reduces reintubation rates - Weaning from mechanical ventilation (5 cmH2O CPAP trials) ### C. Neonatal - Respiratory Distress Syndrome (RDS) / hyaline membrane disease - Prevents atelectasis, minimizes lung injury, preserves surfactant function - Allows management without endotracheal intubation - Early delivery-room CPAP decreases need for mechanical ventilation ### D. One-Lung Ventilation (thoracic surgery) - Applied to the non-ventilated lung to improve oxygenation - Scott-Brown's Otorhinolaryngology; Sabiston Textbook of Surgery; Morgan & Mikhail's Clinical Anesthesiology; Creasy & Resnik's Maternal-Fetal Medicine --- ## CPAP Titration Methods ### 1. In-Lab Polysomnography (PSG) Titration - Diagnostic PSG in first half of night, CPAP titration in second half ("split-night") - Starting pressure ~4 cmH2O, increased until apneas and hypopneas eliminated - Technologist adjusts pressure via central computer with video access to patient - Disadvantage: true severity may not be captured in first half of night ### 2. AutoCPAP (Home Trial) - Patient sent home with an auto-titrating device - Trial of 7-14 days (preferred over 1-night trial) - Machine collects data: compliance, leaks, pressure profile - Fixed pressure then set at 90th or 95th centile pressure from autoCPAP data ### 3. Mathematical Formula - Predicted pressure (cmH2O) = (0.16 × BMI) + (0.13 × NC) + (0.04 × AHI) - 5.12 - NC = neck circumference (cm), AHI = apnea-hypopnea index - Scott-Brown's Otorhinolaryngology --- ## Physiological Effects ### Pulmonary Effects - Increases FRC - Recruits collapsed alveoli (at pressures above the inflection point) - Improves lung compliance - Reduces V/Q mismatch - Decreases intrapulmonary shunting - Improves arterial oxygenation (PaO2) - Redistributes extravascular lung water to peribronchial areas ### Cardiovascular Effects (adverse) - Reduces venous return to the heart (increased intrathoracic pressure) - Reduces cardiac output (especially at pressures >15 cmH2O) - Leftward shift of interventricular septum (raised RV volume) - reduces LV compliance - Reduced renal and hepatic blood flow - Decreased urinary output, GFR, free water clearance - May increase intracranial pressure (impedes cerebral venous drainage) - Morgan & Mikhail's Clinical Anesthesiology, 7e --- ## Benefits of CPAP in OSA (Clinical Outcomes) - Eliminates apneas and hypopneas - Reduces daytime somnolence (dose-dependent: longer use per night = better improvement) - Improves neurocognitive function - Reduces cardiovascular risk (blood pressure, arrhythmia risk) - Improves quality of life - Average use in compliant patients: **2-6 hours per night** --- ## Side Effects / Adverse Effects ### Mask/Interface Related - **Nasal congestion** and rhinosinusitis (most common) - Nasal bridge and facial skin irritation/pressure sores - Epistaxis (nosebleeds) - Claustrophobia (common cause of non-compliance) - Dry mouth / xerostomia ### Pressure-Related - Gastric distention and regurgitation risk (if pressure >15 cmH2O via mask) - Aerophagia - Central sleep apnea emergence (complex/treatment-emergent sleep apnea) ### Machine-Related - Noise of the machine causing sleep disturbance - Inconvenience of carrying equipment (travel) ### Systemic (at high pressures) - Reduced cardiac output - Hypotension - Elevated intracranial pressure --- ## Contraindications - Absent airway protective reflexes (risk of aspiration if mask used) - Facial trauma / burns precluding mask use - Recent facial/upper airway surgery - Uncooperative patient - CSF rhinorrhea / basal skull fracture - Severe hemodynamic instability - Need for emergent intubation - Sabiston Textbook of Surgery --- ## Compliance and Follow-Up - **Poor compliance** is the main limitation of CPAP therapy - Causes of non-compliance: mask discomfort, noise, claustrophobia, nasal symptoms - Strategies to improve compliance: - Patient education programs (group video workshops) - Trying different mask interfaces - Adding humidifiers - Cognitive behavioural therapy (CBT) - Annual electrical safety check mandatory (NHS); engineer downloads compliance data - Significant weight gain may require pressure increase --- ## Alternatives to CPAP | Alternative | Notes | |---|---| | **BiPAP** (Bilevel PAP) | Separate IPAP (10-20 cmH2O) and EPAP (5-10 cmH2O); better for hypercarbic failure and CPAP-intolerant patients | | **Adaptive Servo-Ventilation (ASV)** | For central sleep apnea (CSA); specialist centre initiation required | | **Nasal EPAP devices** | Novel; awaiting RCT vs CPAP | | **Mandibular advancement devices** | For mild-moderate OSA; 50-75% compliance | | **Weight loss** | Adjunct - reduces pressure requirements | | **Surgery** | Uvulopalatopharyngoplasty, maxillomandibular advancement - for selected cases | - Scott-Brown's Otorhinolaryngology --- ## Summary Box for Exam (Rapid Revision) | Parameter | Value/Point | |---|---| | Pressure range (OSA) | 5-10 cmH2O | | Max via mask | 15 cmH2O | | Starting pressure (titration) | ~4 cmH2O | | Average compliant use | 2-6 hours/night | | Fixed pressure set at | 90th-95th centile of auto-CPAP data | | Mechanism in OSA | Pneumatic splint - prevents airway collapse | | Mechanism in ARDS/APE | Increases FRC, recruits alveoli, reduces shunt | | Key side effect | Poor compliance; nasal congestion | | Contraindication (pressure) | >15 cmH2O via mask only (use ETT/trach) | | NICE recommendation | Treatment of choice for moderate-severe OSA | --- **Sources:** - *Morgan & Mikhail's Clinical Anesthesiology, 7e* - CPAP vs PEEP, pulmonary effects, adverse effects - *Scott-Brown's Otorhinolaryngology Head & Neck Surgery* - CPAP in OSA, titration, alternatives - *Sabiston Textbook of Surgery* - Noninvasive ventilation, CPAP/BiPAP in ICU - *Creasy & Resnik's Maternal-Fetal Medicine* - Neonatal CPAP in RDS - *Miller's Anesthesia, 10e* - Postoperative CPAP use